Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q1 2023 vs. Q4 2022
How the institutions holding Apollomics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 0 | 8 | +8 |
| Shares | 0 | 1.37M | +1.37M |
| Value | $0 | $33.1M | +$33.1M |
New holders (8)
Institutions that held Apollomics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| George Kaiser Family Foundation | 670,976 | $16.2M | 2.62% |
| OrbiMed Advisors LLC | 662,561 | $16.0M | 0.32% |
| Geode Capital Management, LLC | 13,427 | $324.9K | 0.00% |
| Johnson & Johnson | 13,252 | $320.7K | 0.10% |
| Clear Street LLC | 6,800 | $164.6K | 0.03% |
| Wells Fargo & Company | 1,578 | $38.2K | 0.00% |
| UBS Group AG | 414 | $10.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 156 | $4.00K | 0.00% |
Sold out (0)
Institutions that held Apollomics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
None.